Canada Pension Plan Investment Board
IBRX icon

Canada Pension Plan Investment Board’s ImmunityBio IBRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$615K Sell
70,200
-14,300
-17% -$108K ﹤0.01% 1189
2026
Q1 		$648K Sell
84,500
-88,300
-51% -$604K ﹤0.01% 1141
2025
Q4 		$342K Buy
+172,800
New +$391K ﹤0.01% 1460
2019
Q2 		– Sell
-200
Closed – – 1352
2019
Q1 		$0 Buy
+200
New +$251 ﹤0.01% 1573

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canada Pension Plan Investment Board's IBRX Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its ImmunityBio (IBRX) stake by 17% in Q2 2026, selling an estimated $108K and leaving 70,200 shares worth $615K. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

Canada Pension Plan Investment Board first reported a position in IBRX in Q1 2019 and has held it in 4 quarters since. The position peaked at $648K in Q1 2026. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Canada Pension Plan Investment Board held 70,200 shares of ImmunityBio worth $615K as of Q2 2026.
  • Canada Pension Plan Investment Board sold 14,300 ImmunityBio shares in Q2 2026, an estimated $108K.
  • ImmunityBio made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1189 holding.
  • Canada Pension Plan Investment Board first reported a position in ImmunityBio in Q1 2019 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's ImmunityBio position peaked at $648K in Q1 2026.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.